Mylan (MYL): Cutting PT Despite Guidance Reiteration On Generic Visibility Worsening - RBC
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
RBC Capital analyst, Randall Stanicky, reiterated his Sector Perform rating on shares of Mylan (NASDAQ: MYL) and cut his price target to $44 after the company missed 3Q revenue and EPS but reaffirmed full year as well as the 2018E target of $6.00 - 2017 outlook will be delivered at the analyst call in Feb.
The call was focused on generic outlook and MYL's insistence on steady mid-single digit erosion and shelter from peer-related competitive headwinds. The analyst stated "we do think MYL has a more defendable business given breadth, diversification and scale but we also think that (i) 2017 generic sector visibility is worsening in general (with MCK/WMT bid cycle ahead) and (ii) competitive pressures are increasing and that, combined with declining Epipen contribution, will add pressure to MYL's consolidated margin in 2017".
The new $44 PT is down from $48.
Shares of Mylan closed at $38.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Cuts Price Target on Workday (WDAY) Following 3Q; Reiterates Outperform
- Jefferies Cuts Price Target on Dollar General (DG) Following 3Q
- Jefferies Raises Price Target on US Physical Therapy (USPH) to $63 Following 12-Clinic Acquisition
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change, Earnings
Related EntitiesRBC Capital
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!